TruBridge, Inc. (NASDAQ:TBRG) Shares Sold by GSA Capital Partners LLP

Key Points

• GSA Capital Partners LLP reduced its stake in TruBridge, Inc. by 44.1% during the first quarter, holding 40,809 shares valued at approximately $1.12 million.
• TruBridge's CEO, Christopher L. Fowler, sold 6,000 shares at an average price of $25.05, resulting in a 4.38% decrease in his ownership.
• Analysts at Stephens issued a target price of $28.00 for TruBridge shares, maintaining an "equal weight" rating following the company's recent earnings report.

GSA Capital Partners LLP reduced its position in shares of TruBridge, Inc. (NASDAQ:TBRG - Free Report) by 44.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 40,809 shares of the company's stock after selling 32,151 shares during the quarter. GSA Capital Partners LLP owned 0.27% of TruBridge worth $1,123,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Tower Research Capital LLC TRC boosted its stake in shares of TruBridge by 47.5% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,170 shares of the company's stock worth $43,000 after acquiring an additional 699 shares during the last quarter. Covestor Ltd grew its holdings in shares of TruBridge by 20.5% during the fourth quarter. Covestor Ltd now owns 2,819 shares of the company's stock worth $56,000 after buying an additional 479 shares in the last quarter. OMERS ADMINISTRATION Corp acquired a new stake in shares of TruBridge in the fourth quarter valued at about $211,000. Two Sigma Securities LLC purchased a new position in shares of TruBridge in the fourth quarter worth about $222,000. Finally, Kingsview Wealth Management LLC purchased a new stake in TruBridge during the 1st quarter valued at about $240,000. Hedge funds and other institutional investors own 88.64% of the company's stock.

TruBridge Trading Up 2.9%

Shares of TBRG stock traded up $0.59 on Monday, hitting $21.13. The stock had a trading volume of 63,408 shares, compared to its average volume of 170,751. The company's 50 day moving average price is $22.96 and its 200-day moving average price is $25.03. TruBridge, Inc. has a 1 year low of $9.75 and a 1 year high of $32.00. The company has a debt-to-equity ratio of 0.98, a current ratio of 1.69 and a quick ratio of 1.68. The firm has a market capitalization of $317.37 million, a P/E ratio of -15.63 and a beta of 0.59.

TruBridge (NASDAQ:TBRG - Get Free Report) last issued its quarterly earnings results on Friday, May 9th. The company reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.37 by ($0.08). TruBridge had a positive return on equity of 0.33% and a negative net margin of 5.86%. The business had revenue of $87.21 million for the quarter, compared to analyst estimates of $86.21 million. Analysts anticipate that TruBridge, Inc. will post 0.07 earnings per share for the current year.

Insider Transactions at TruBridge

In related news, CEO Christopher L. Fowler sold 6,000 shares of TruBridge stock in a transaction on Friday, May 16th. The shares were sold at an average price of $25.05, for a total transaction of $150,300.00. Following the sale, the chief executive officer directly owned 131,090 shares in the company, valued at $3,283,804.50. This trade represents a 4.38% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 10.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Separately, Stephens reissued an "equal weight" rating and issued a $28.00 price objective on shares of TruBridge in a report on Thursday, April 10th.

TruBridge Company Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.